Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CFO and Corporate Secretary

President and CEO

Chief Business Officer

Chief Medical Officer

Chief Operating Officer

Chief Financial Officer

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; AVISE Anti-CarP test, which identifies RA patients with severe disease; and AVISE PC4d to measure platelet- bound C4d. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under t...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-04	Premium	sold	Premium	Premium	Premium	CFO and Corporate Secretary
2024-02-29	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-20	Premium	acquired	Premium	Premium	Premium	CFO and Corporate Secretary
2024-02-20	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-06	Premium	sold	Premium	Premium	Premium	CFO and Corporate Secretary
2023-10-17	Premium	sold	Premium	Premium	Premium	President and CEO
2023-08-31	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-15	Premium	bought	Premium	Premium	Premium	-
2023-03-02	Premium	sold	Premium	Premium	Premium	CFO and Corporate Secretary
2023-03-02	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2023-02-27	Premium	acquired	Premium	Premium	Premium	CFO and Corporate Secretary
2023-02-27	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2023-02-08	Premium	sold	Premium	Premium	Premium	CFO and Corporate Secretary
2023-02-08	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2022-12-08	Premium	bought	Premium	Premium	Premium	President and CEO
2022-10-16	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-03-01	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2022-03-01	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2022-03-01	Premium	sold (taxes)	Premium	Premium	Premium	CFO and Corporate Secretary
2022-03-01	Premium	sold (taxes)	Premium	Premium	Premium	Chief Operating Officer
2022-02-04	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-02-04	Premium	acquired	Premium	Premium	Premium	CFO and Corporate Secretary
2022-02-04	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-02-04	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2021-09-03	Premium	bought	Premium	Premium	Premium	-

XGN - Exagen Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for XGN